We investigated how previous immunity and intrinsic immunogenicity affect the generation of immune responses to SARS-CoV-2 variants. Although previous immunity partially reduces subtype-specific responses to a new virus variant, we found that poor immunogenicity of the mutated epitopes in the infecting virus has a larger effect on limiting new responses.
This is a preview of subscription content, access via your institution
Access options

References
Francis, T. On the doctrine of original antigenic sin. Proc. Am. Philos. Soc. 104, 572–578 (1960). This paper proposes a concept that antibodies generated in response to initial exposure to influenza virus in childhood dominate the antibody response of an individual for life.
Cobey, S. Vaccination against rapidly evolving pathogens and the entanglements of memory. Nat. Immunol. 25, 2015–2023 (2024). A review article that describes the difficulties in predicting how pre-existing immunity will affect immune responses elicited by vaccines against antigenically evolving pathogens.
Morens, D. M. & Fauci, A. S. The 1918 influenza pandemic: insights for the 21st century. J. Infect. Dis. 195, 1018–1028 (2007). This paper summarizes the 1918 influenza pandemic mortality and progression.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Quirk, G. E. et al. Intrinsic immunogenicity is a major determinant of type-specific responses in post-vaccination SARS-CoV-2 infections. Nat. Immunol. https://doi.org/10.1038/s41590-025-02162-2 (2025).
Rights and permissions
About this article
Cite this article
Mutated epitopes in SARS-CoV-2 variants are poorly immunogenic. Nat Immunol 26, 825–826 (2025). https://doi.org/10.1038/s41590-025-02164-0
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41590-025-02164-0